Cargando…

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) outcomes are improving since the implementation of immunotherapy. However, objective response rates are still limited to a select group of patients. This is partly due to TNBC intrinsic immune evasive mechanisms and the lack of proper tumor microe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llinàs-Arias, Pere, Íñiguez-Muñoz, Sandra, McCann, Kelly, Voorwerk, Leonie, Orozco, Javier I. J., Ensenyat-Mendez, Miquel, Sesé, Borja, DiNome, Maggie L., Marzese, Diego M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394958/ https://www.ncbi.nlm.nih.gov/pubmed/34439290 http://dx.doi.org/10.3390/cancers13164139

Ejemplares similares

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2023)

Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology
por: Sesé, Borja, et al.
Publicado: (2021)

Correction to: Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology
por: Sesé, Borja, et al.
Publicado: (2021)

iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Correction to: iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype
por: Sesé, Borja, et al.
Publicado: (2022)

Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors
por: Llinàs-Arias, Pere, et al.
Publicado: (2023)

3-D chromatin conformation, accessibility, and gene expression profiling of triple-negative breast cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2023)

Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer
por: Bustos, Matias A., et al.
Publicado: (2017)

Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer
por: Nederlof, Iris, et al.
Publicado: (2023)

Anaphylactic Reaction to Lymphazurin 1% during Breast Reconstruction Surgery: An Uncommon but Serious Complication
por: Krishna, Vikram, et al.
Publicado: (2020)

Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)

Epigenetically regulated PCDHB15 impairs aggressiveness of metastatic melanoma cells
por: Carrier, Arnaud, et al.
Publicado: (2022)

Epigenetic Classifiers for Precision Diagnosis of Brain Tumors
por: Orozco, Javier IJ, et al.
Publicado: (2019)

Microbial Dysbiosis Is Associated with Human Breast Cancer
por: Xuan, Caiyun, et al.
Publicado: (2014)

Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute
por: Parra, Maribel, et al.
Publicado: (2020)

Beyond the immediate tumor microenvironment: distinct T cell phenotype and function of tumor-adjacent healthy breast tissue associated with regional metastasis in breast cancer
por: Guo, Yi, et al.
Publicado: (2014)

Aln2tbl: building a mitochondrial features table from a assembly alignment in fasta format
por: Pons, Joan, et al.
Publicado: (2021)

Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: acceleration and compressed sensing reconstruction
por: Joy, Ajin, et al.
Publicado: (2022)

Methylation profile of triple-negative breast carcinomas
por: Branham, M T, et al.
Publicado: (2012)

How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support
por: Berkowitz, Maurice J., et al.
Publicado: (2020)

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
por: Nguyen, Vina P., et al.
Publicado: (2023)

When left does not seem right: epigenetic and bioelectric differences between left- and right-sided breast cancer
por: Masuelli, Sofía, et al.
Publicado: (2022)

Epigenetic responses to stress: triple defense?
por: Gutzat, Ruben, et al.
Publicado: (2012)

Epigenetic Perspective of Immunotherapy for Cancers
por: Keshari, Sunita, et al.
Publicado: (2023)

Correction to: When left does not seem right: epigenetic and bioelectric differences between left and right‑sided breast cancer
por: Masuelli, Sofia, et al.
Publicado: (2022)

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
por: Zhang, Zengfu, et al.
Publicado: (2023)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer
por: Rosselló-Tortella, Margalida, et al.
Publicado: (2020)

Epigenetic Strategies to Boost Cancer Immunotherapies
por: Barrero, Maria J.
Publicado: (2017)

Leveraging epigenetics to enhance the efficacy of immunotherapy
por: Licht, Jonathan D., et al.
Publicado: (2021)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

“In my age, we didn’t have the computers”: Using a complexity lens to understand uptake of diabetes eHealth innovations into primary care—A qualitative study
por: Yu, Catherine H., et al.
Publicado: (2021)

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
por: Hammerl, Dora, et al.
Publicado: (2021)

P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
por: Martinez-Verbo, Laura, et al.
Publicado: (2023)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t6dai1fsjmqj07q1motuo73n7p